Skip to main content
Top
Published in: Current Heart Failure Reports 2/2012

01-06-2012 | Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section editor)

Role of Physical Training in Heart Failure with Preserved Ejection Fraction

Authors: Mark Haykowsky, Peter Brubaker, Dalane Kitzman

Published in: Current Heart Failure Reports | Issue 2/2012

Login to get access

Abstract

About 50 % or more of heart failure (HF) patients living in the community have preserved left ventricular ejection fraction (HFpEF), and the proportion is higher among women and the very elderly. A cardinal feature of HFpEF is reduced aerobic capacity, measured objectively as peak exercise pulmonary oxygen uptake (peak VO2), that results in decreased quality of life. Specifically, peak VO2 of HFpEF patients is 30–70 % lower than age-, sex-, and comorbidity-matched control patients without HF. The mechanisms for the reduced peak VO2 are due to cardiovascular and skeletal muscle dysfunction that results in reduced oxygen delivery to and/or utilization by the active muscles. Currently, four randomized controlled exercise intervention trials have been performed in HFpEF patients. These studies have consistently demonstrated that 3–6 months of aerobic training performed alone or in combination with strength training is a safe and effective therapy to increase aerobic capacity and endurance and quality of life in HFpEF patients. Despite these benefits, the physiologic mechanisms underpinning the improvement in peak exercise performance have not been studied; therefore, future studies are required to determine the role of physical training to reverse the impaired cardiovascular and skeletal muscle function in HFpEF patients.
Literature
1.
go back to reference Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G, Marino EK, Lyles M, Cushman M, Enright PL. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol. 2001;87(4):413–9.PubMedCrossRef Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G, Marino EK, Lyles M, Cushman M, Enright PL. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol. 2001;87(4):413–9.PubMedCrossRef
2.
go back to reference Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33(7):1948–55.PubMedCrossRef Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33(7):1948–55.PubMedCrossRef
3.
go back to reference Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355(3):260–9.PubMedCrossRef Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355(3):260–9.PubMedCrossRef
4.
go back to reference Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan MJ. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol. 1991;17(5):1065–72.PubMedCrossRef Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan MJ. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol. 1991;17(5):1065–72.PubMedCrossRef
5.
go back to reference Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC, Kass DA. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation. 2006;114(20):2138–47.PubMedCrossRef Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC, Kass DA. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation. 2006;114(20):2138–47.PubMedCrossRef
6.
go back to reference • Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, Redfield MM. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2010;56(11):845–54. This study showed that the reduced exercise tolerance in HFpEF patients versus age and sex-matched healthy or hypertensive control patients without heart failure was the result of impaired chronotropic, inotropic, and vascular reserve.PubMedCrossRef • Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, Redfield MM. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2010;56(11):845–54. This study showed that the reduced exercise tolerance in HFpEF patients versus age and sex-matched healthy or hypertensive control patients without heart failure was the result of impaired chronotropic, inotropic, and vascular reserve.PubMedCrossRef
7.
go back to reference • Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of Exercise Intolerance in Elderly Heart Failure Patients with Preserved Ejection Fraction. J Am Coll Cardiol. 2011;58(3):265–74. This study found that the reduced peak VO 2 in elderly HFpEF patients versus age-matched healthy control patients was the result of a reduced cardiac output and arterial-venous oxygen difference. Further, the strongest independent predictor of peak VO 2 was the change in arterial-venous oxygen difference from rest to peak exercise for both HFpEF patients and healthy control patients.PubMedCrossRef • Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of Exercise Intolerance in Elderly Heart Failure Patients with Preserved Ejection Fraction. J Am Coll Cardiol. 2011;58(3):265–74. This study found that the reduced peak VO 2 in elderly HFpEF patients versus age-matched healthy control patients was the result of a reduced cardiac output and arterial-venous oxygen difference. Further, the strongest independent predictor of peak VO 2 was the change in arterial-venous oxygen difference from rest to peak exercise for both HFpEF patients and healthy control patients.PubMedCrossRef
8.
go back to reference • Bhella PS, Prasad A, Heinicke K, Hastings JL, Arbab-Zadeh A, Adams-Huet B, Pacini EL, Shibata S, Palmer MD, Newcomer BR, et al. Abnormal hemodynamic response to exercise in heart failure with preserved ejection fraction. Eur J Hear Fail. 2011;13:1296–304. This study demonstrated that the reduced peak VO 2 in elderly HFpEF patients versus age-matched sedentary control patients was due to a lower peak arterial-venous oxygen difference as peak cardiac output was not significantly different between groups. In addition, preliminary analysis also revealed impaired skeletal muscle oxidative metabolism in HFpEF patients.CrossRef • Bhella PS, Prasad A, Heinicke K, Hastings JL, Arbab-Zadeh A, Adams-Huet B, Pacini EL, Shibata S, Palmer MD, Newcomer BR, et al. Abnormal hemodynamic response to exercise in heart failure with preserved ejection fraction. Eur J Hear Fail. 2011;13:1296–304. This study demonstrated that the reduced peak VO 2 in elderly HFpEF patients versus age-matched sedentary control patients was due to a lower peak arterial-venous oxygen difference as peak cardiac output was not significantly different between groups. In addition, preliminary analysis also revealed impaired skeletal muscle oxidative metabolism in HFpEF patients.CrossRef
9.
go back to reference Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA. 2002;288(17):2144–50.PubMedCrossRef Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA. 2002;288(17):2144–50.PubMedCrossRef
10.
go back to reference Wilson JR, Mancini DM, Dunkman WB. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation. 1993;87(2):470–5.PubMed Wilson JR, Mancini DM, Dunkman WB. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation. 1993;87(2):470–5.PubMed
11.
go back to reference Esposito F, Mathieu-Costello O, Shabetai R, Wagner PD, Richardson RS. Limited maximal exercise capacity in patients with chronic heart failure: partitioning the contributors. J Am Coll Cardiol. 2010;55(18):1945–54.PubMedCrossRef Esposito F, Mathieu-Costello O, Shabetai R, Wagner PD, Richardson RS. Limited maximal exercise capacity in patients with chronic heart failure: partitioning the contributors. J Am Coll Cardiol. 2010;55(18):1945–54.PubMedCrossRef
12.
go back to reference Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation. 1989;80(4):769–81.PubMedCrossRef Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation. 1989;80(4):769–81.PubMedCrossRef
13.
go back to reference Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation. 1992;85(4):1364–73.PubMed Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation. 1992;85(4):1364–73.PubMed
14.
go back to reference Katz SD, Maskin C, Jondeau G, Cocke T, Berkowitz R, LeJemtel T. Near-maximal fractional oxygen extraction by active skeletal muscle in patients with chronic heart failure. J Appl Physiol. 2000;88(6):2138–42.PubMed Katz SD, Maskin C, Jondeau G, Cocke T, Berkowitz R, LeJemtel T. Near-maximal fractional oxygen extraction by active skeletal muscle in patients with chronic heart failure. J Appl Physiol. 2000;88(6):2138–42.PubMed
15.
go back to reference Weber KT, Kinasewitz GT, Janicki JS, Fishman AP. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation. 1982;65(6):1213–23.PubMedCrossRef Weber KT, Kinasewitz GT, Janicki JS, Fishman AP. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation. 1982;65(6):1213–23.PubMedCrossRef
16.
go back to reference Higginbotham MB, Morris KG, Conn EH, Coleman RE, Cobb FR. Determinants of variable exercise performance among patients with severe left ventricular dysfunction. Am J Cardiol. 1983;51(1):52–60.PubMedCrossRef Higginbotham MB, Morris KG, Conn EH, Coleman RE, Cobb FR. Determinants of variable exercise performance among patients with severe left ventricular dysfunction. Am J Cardiol. 1983;51(1):52–60.PubMedCrossRef
17.
go back to reference Katz SD, Zheng H. Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure. J Nucl Cardiol. 2002;9(2):215–25.PubMedCrossRef Katz SD, Zheng H. Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure. J Nucl Cardiol. 2002;9(2):215–25.PubMedCrossRef
18.
go back to reference Poole DC, Hirai DM, Copp SW, Musch TI. Muscle oxygen transport and utilization in heart failure: implications for exercise (In)tolerance. Am J Physiol Heart Circ Physiol 2011. Poole DC, Hirai DM, Copp SW, Musch TI. Muscle oxygen transport and utilization in heart failure: implications for exercise (In)tolerance. Am J Physiol Heart Circ Physiol 2011.
19.
go back to reference Kitzman DW. Understanding results of trials in heart failure with preserved ejection fraction: remembering forgotten lessons and enduring principles. J Am Coll Cardiol. 2011;57(16):1687–9.PubMedCrossRef Kitzman DW. Understanding results of trials in heart failure with preserved ejection fraction: remembering forgotten lessons and enduring principles. J Am Coll Cardiol. 2011;57(16):1687–9.PubMedCrossRef
20.
go back to reference Kitzman DW. Exercise training in heart failure with preserved ejection fraction: beyond proof-of-concept. J Am Coll Cardiol. 2011;58(17):1792–4.PubMedCrossRef Kitzman DW. Exercise training in heart failure with preserved ejection fraction: beyond proof-of-concept. J Am Coll Cardiol. 2011;58(17):1792–4.PubMedCrossRef
21.
go back to reference Paterson DH, Cunningham DA, Koval JJ. St Croix CM: aerobic fitness in a population of independently living men and women aged 55–86 years. Med Sci Sports Exerc. 1999;31(12):1813–20.PubMedCrossRef Paterson DH, Cunningham DA, Koval JJ. St Croix CM: aerobic fitness in a population of independently living men and women aged 55–86 years. Med Sci Sports Exerc. 1999;31(12):1813–20.PubMedCrossRef
22.
go back to reference Warburton DER, Taylor A, Bredin SSD, Esch BTA, Scott JM, Haykowsky MJ. Central haemodynamics and peripheral muscle function during exercise in patients with chronic heart failure. Appl Physiol Nutr Me. 2007;32(2):318–31.CrossRef Warburton DER, Taylor A, Bredin SSD, Esch BTA, Scott JM, Haykowsky MJ. Central haemodynamics and peripheral muscle function during exercise in patients with chronic heart failure. Appl Physiol Nutr Me. 2007;32(2):318–31.CrossRef
23.
go back to reference Ennezat PV, Lefetz Y, Marechaux S, Six-Carpentier M, Deklunder G, Montaigne D, Bauchart JJ, Mounier-Vehier C, Jude B, Neviere R, et al. Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest. J Card Fail. 2008;14(6):475–80.PubMedCrossRef Ennezat PV, Lefetz Y, Marechaux S, Six-Carpentier M, Deklunder G, Montaigne D, Bauchart JJ, Mounier-Vehier C, Jude B, Neviere R, et al. Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest. J Card Fail. 2008;14(6):475–80.PubMedCrossRef
24.
go back to reference Lele SS, Thomson HL, Seo H, Belenkie I, McKenna WJ, Frenneaux MP. Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics. Circulation. 1995;92(10):2886–94.PubMed Lele SS, Thomson HL, Seo H, Belenkie I, McKenna WJ, Frenneaux MP. Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics. Circulation. 1995;92(10):2886–94.PubMed
25.
go back to reference Gary R. Exercise self-efficacy in older women with diastolic heart failure: results of a walking program and education intervention. J Gerontol Nurs. 2006;32(7):31–9. quiz 40–31.PubMed Gary R. Exercise self-efficacy in older women with diastolic heart failure: results of a walking program and education intervention. J Gerontol Nurs. 2006;32(7):31–9. quiz 40–31.PubMed
26.
go back to reference •• Kitzman DW, Brubaker PH, Morgan TM, Stewart KP, Little WC. Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. Circ Heart Fail. 2010;3(6):659–67. This was the first randomized controlled trial to compare the effects of 16 weeks of supervised endurance exercise training versus attention control on aerobic capacity and endurance, left ventricular morphology, neurohormones, and quality of life in 46 elderly HFpEF patients. Endurance exercise training was a safe and effective intervention that resulted in a significant improvement in aerobic capacity and endurance and physical quality of life.PubMedCrossRef •• Kitzman DW, Brubaker PH, Morgan TM, Stewart KP, Little WC. Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. Circ Heart Fail. 2010;3(6):659–67. This was the first randomized controlled trial to compare the effects of 16 weeks of supervised endurance exercise training versus attention control on aerobic capacity and endurance, left ventricular morphology, neurohormones, and quality of life in 46 elderly HFpEF patients. Endurance exercise training was a safe and effective intervention that resulted in a significant improvement in aerobic capacity and endurance and physical quality of life.PubMedCrossRef
27.
go back to reference •• Edelmann F, Gelbrich G, Dungen HD, Frohling S, Wachter R, Stahrenberg R, Binder L, Topper A, Lashki DJ, Schwarz S, et al. Exercise Training Improves Exercise Capacity and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction Results of the Ex-DHF (Exercise training in Diastolic Heart Failure) Pilot Study. J Am Coll Cardiol. 2011;58(17):1780–91. This was the first multicenter exercise intervention trial to compare the effects of 12 weeks of supervised endurance and strength training versus usual care on aerobic capacity and endurance, diastolic function, biomarkers, and quality of life in 64 HFpEF patients. Combined training for 12 weeks was a safe and effective intervention that resulted in favorable improvements in aerobic capacity and endurance, diastolic function, and physical quality of life.PubMedCrossRef •• Edelmann F, Gelbrich G, Dungen HD, Frohling S, Wachter R, Stahrenberg R, Binder L, Topper A, Lashki DJ, Schwarz S, et al. Exercise Training Improves Exercise Capacity and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction Results of the Ex-DHF (Exercise training in Diastolic Heart Failure) Pilot Study. J Am Coll Cardiol. 2011;58(17):1780–91. This was the first multicenter exercise intervention trial to compare the effects of 12 weeks of supervised endurance and strength training versus usual care on aerobic capacity and endurance, diastolic function, biomarkers, and quality of life in 64 HFpEF patients. Combined training for 12 weeks was a safe and effective intervention that resulted in favorable improvements in aerobic capacity and endurance, diastolic function, and physical quality of life.PubMedCrossRef
28.
go back to reference Alves AJ, Ribeiro F, Goldhammer E, Rivlin Y, Rosenschein U, Viana JL, Duarte JA, Sagiv M, Oliveira J. Exercise training improves diastolic function in heart failure patients. Med Sci Sports Exerc 2011. Alves AJ, Ribeiro F, Goldhammer E, Rivlin Y, Rosenschein U, Viana JL, Duarte JA, Sagiv M, Oliveira J. Exercise training improves diastolic function in heart failure patients. Med Sci Sports Exerc 2011.
29.
go back to reference Piepoli MF, Conraads V, Corra U, Dickstein K, Francis DP, Jaarsma T, McMurray J, Pieske B, Piotrowicz E, Schmid JP, et al. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail. 2011;13(4):347–57.PubMedCrossRef Piepoli MF, Conraads V, Corra U, Dickstein K, Francis DP, Jaarsma T, McMurray J, Pieske B, Piotrowicz E, Schmid JP, et al. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail. 2011;13(4):347–57.PubMedCrossRef
30.
go back to reference Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, Tjonna AE, Helgerud J, Slordahl SA, Lee SJ, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation. 2007;115(24):3086–94.PubMedCrossRef Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, Tjonna AE, Helgerud J, Slordahl SA, Lee SJ, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation. 2007;115(24):3086–94.PubMedCrossRef
31.
go back to reference Esposito F, Reese V, Shabetai R, Wagner PD, Richardson RS. Isolated quadriceps training increases maximal exercise capacity in chronic heart failure: the role of skeletal muscle convective and diffusive oxygen transport. J Am Coll Cardiol. 2011;58(13):1353–62.PubMedCrossRef Esposito F, Reese V, Shabetai R, Wagner PD, Richardson RS. Isolated quadriceps training increases maximal exercise capacity in chronic heart failure: the role of skeletal muscle convective and diffusive oxygen transport. J Am Coll Cardiol. 2011;58(13):1353–62.PubMedCrossRef
Metadata
Title
Role of Physical Training in Heart Failure with Preserved Ejection Fraction
Authors
Mark Haykowsky
Peter Brubaker
Dalane Kitzman
Publication date
01-06-2012
Publisher
Current Science Inc.
Published in
Current Heart Failure Reports / Issue 2/2012
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-012-0087-7

Other articles of this Issue 2/2012

Current Heart Failure Reports 2/2012 Go to the issue

Management of Heart Failure (TE Meyer, Section editor)

Cardiac Ultrasound Imaging in Heart Failure: Recent Advances

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section editor)

The Neurohormonal Network in the RAAS Can Bend Before Breaking

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section editor)

Receptor for Advanced Glycation End Products (RAGE) and Implications for the Pathophysiology of Heart Failure

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine